INS and atherosclerosis: Their investigations in diet-induced obesity and atherosclerosis mouse models demonstrated that LApBIN could effectively target deliver drug to multiple lesions including inflammatory adipose tissue, fatty liver, and atherosclerosis; furthermore, LApBIN administrattion could also ameliorate insulin resistance (Figure 6).